Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-02 09:53 am Sale | 13G | Cocrystal Pharma Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -420,710 (Position Closed) | View |
| 2023-04-14 4:01 pm Purchase | 13D | Cocrystal Pharma Inc. COCP | FROST PHILLIP MD | 1,332,608 13.100% | 1,332,608 (New Position) | View |
| 2023-04-12 4:09 pm Purchase | 13G | Cocrystal Pharma Inc. COCP | Hassan Fred | 1,015,229 10.000% | 1,015,229 (New Position) | View |
| 2023-01-10 11:40 am Sale | 13G | Cocrystal Pharma Inc. COCP | SABBY MANAGEMENT LLC | 420,710 11.000% | -5,317,410 (-92.67%) | View |
| 2022-02-10 3:49 pm Sale | 13G | Cocrystal Pharma Inc. COCP | RENAISSANCE TECHNOLOGIES LLC | 1,902,925 1.950% | -2,047,055 (-51.82%) | View |
| 2022-01-03 9:47 pm Sale | 13G | Cocrystal Pharma Inc. COCP | SABBY MANAGEMENT LLC | 5,738,120 11.000% | -4,001,880 (-41.09%) | View |
| 2021-06-09 5:44 pm Purchase | 13D | Cocrystal Pharma Inc. COCP | FROST PHILLIP MD | 3,726,306 3.800% | 3,726,306 (New Position) | View |
| 2021-05-25 1:15 pm Unchanged | 13D | Cocrystal Pharma Inc. COCP | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | View |
| 2021-05-17 5:13 pm Purchase | 13G | Cocrystal Pharma Inc. COCP | Ayrton Capital LLC | 6,520,000 6.690% | 6,520,000 (New Position) | View |
| 2021-05-12 2:13 pm Purchase | 13G | Cocrystal Pharma Inc. COCP | SABBY MANAGEMENT LLC | 9,740,000 11.000% | 9,740,000 (New Position) | View |
| 2021-02-16 09:46 am Sale | 13G | Cocrystal Pharma Inc. COCP | CVI Investments Inc. | 0 0.000% | -3,461,539 (Position Closed) | View |
| 2021-02-10 10:12 am Purchase | 13G | Cocrystal Pharma Inc. COCP | RENAISSANCE TECHNOLOGIES LLC | 3,949,980 5.760% | 3,949,980 (New Position) | View |
| 2021-01-05 09:26 am Sale | 13G | Cocrystal Pharma Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -3,461,539 (Position Closed) | View |
| 2020-11-19 4:01 pm Purchase | 13D | Cocrystal Pharma Inc. COCP | OPKO HEALTH INC. OPK | 3,695,056 5.400% | 9,375 (+0.25%) | View |
| 2020-03-10 4:10 pm Purchase | 13D | Cocrystal Pharma Inc. COCP | OPKO HEALTH INC. OPK | 3,685,681 7.800% | 3,125 (+0.08%) | View |
| 2020-03-06 09:25 am Purchase | 13G | Cocrystal Pharma Inc. COCP | CVI Investments Inc. | 3,461,539 7.300% | 3,461,539 (New Position) | View |
| 2020-03-03 1:14 pm Sale | 13G | Cocrystal Pharma Inc. COCP | WASATCH ADVISORS LP | 0 0.000% | -1,799,496 (Position Closed) | View |
| 2020-02-28 4:32 pm Sale | 13G | Cocrystal Pharma Inc. COCP | LSP Advisory B.V. | 1,633,035 4.200% | -900,423 (-35.54%) | View |
| 2020-02-27 11:57 am Purchase | 13G | Cocrystal Pharma Inc. COCP | SABBY MANAGEMENT LLC | 3,461,539 11.000% | 3,461,539 (New Position) | View |
| 2020-02-10 4:31 pm Purchase | 13G | Cocrystal Pharma Inc. COCP | LSP Advisory B.V. | 2,533,458 7.200% | 648,064 (+34.37%) | View |